Institutional Training Programs to Advance Translational Research on Alzheimers Disease and AD Related Dementias (T32) | RFA AG 17 063

Opportunity Information: Apply for RFA AG 17 063

Institutional Training Programs to Advance Translational Research on Alzheimers Disease and AD Related Dementias (T32) is a National Institutes of Health (NIH) grant opportunity focused on building a stronger, more interdisciplinary research workforce aimed at Alzheimers disease and Alzheimers disease related dementias (often grouped as ADRD). The core idea is to support institutional training programs that prepare both predoctoral and postdoctoral researchers to work effectively across disciplines, especially in environments where solving problems requires coordinated teams rather than isolated single-lab efforts. The FOA is designed around the reality that modern Alzheimers and dementia research is increasingly data-intensive and translational, meaning it needs people who can connect basic biology to therapeutic discovery and development.

This opportunity uses the T32 institutional training mechanism, which generally means funding is awarded to an institution to run a structured training program rather than to support a single trainee directly. Under this FOA, the training programs are expected to recruit and develop trainees coming from several relevant backgrounds, including biology, data sciences, and both traditional and emerging pharmaceutical sciences. The emphasis is not just on producing specialists in one narrow area, but on developing scientists who can communicate across fields and contribute to team-based approaches for tackling complex biomedical questions. The program’s training focus includes skills and knowledge needed for basic research and therapy development for Alzheimers disease and related dementias, reflecting a translational pipeline mindset that spans from understanding disease mechanisms to enabling the discovery of interventions.

A major theme in the description is readiness to address data-heavy biomedical problems. In practical terms, this points to training that equips researchers to work with large-scale datasets and computational or quantitative approaches alongside wet-lab biology and drug development strategies. The FOA frames this as a workforce development need: trainees should be prepared to participate in collaborative, interdisciplinary teams that can integrate diverse forms of evidence, methods, and tools in order to accelerate progress in Alzheimers and ADRD research.

Eligibility is broad across U.S.-based organizations that can host and administer an institutional training program. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3), as long as they are not higher education institutions in those nonprofit categories), federally recognized Native American tribal governments, and Native American tribal organizations other than federally recognized tribal governments, as well as other applicants as allowed under NIH rules. The FOA also explicitly highlights additional eligible applicant types, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American tribal governments other than federally recognized entities, and Tribally Controlled Colleges and Universities (TCCUs), as well as U.S. territories or possessions. At the same time, the announcement clearly states that non-domestic (non-U.S.) entities are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible, keeping the program fully within domestic institutional training environments.

From the source details provided, the opportunity is identified as RFA AG 17 063, categorized as discretionary funding, and uses a grant funding instrument. The activity area is health, and the CFDA number listed is 93.866. The FOA was created on 2016-12-05, with an original closing date of 2017-02-03. No award ceiling or expected number of awards is specified in the provided text, which suggests applicants would need to consult the full FOA or NIH guidance for budget structure, allowable costs, trainee support levels, and program requirements typically associated with T32 awards.

Overall, this FOA is best understood as a capacity-building and workforce pipeline initiative: it funds institutions to create robust, interdisciplinary training environments that produce the next generation of scientists capable of translating discoveries into therapeutic advances for Alzheimers disease and related dementias, with particular emphasis on collaboration, data-driven research, and bridging biology with pharmaceutical and computational sciences.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimers Disease and AD Related Dementias (T32)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
• This funding opportunity was created on 2016-12-05.
• Applicants must submit their applications by 2017-02-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Others.

Apply for RFA AG 17 063

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: